Drug profile · INN
tranylcypromine
PARNATE
tranylcypromine (PARNATE) is a monoamine oxidase inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — tranylcypromine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
tranylcypromine (PARNATE) is a monoamine oxidase inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited.
Key facts
INN tranylcypromine
Brand PARNATE
Mechanism Monoamine oxidase inhibitor
Originator Amdipharm Mercury (Australia) Pty Limited
Mechanism of action
Monoamine oxidase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is tranylcypromine?
tranylcypromine (PARNATE) is a monoamine oxidase inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited.
What is the brand name for tranylcypromine?
PARNATE is a marketed brand name for tranylcypromine. Check FDA Drugs@FDA for the current US label holder and prescribing information.